Print

HVTN 110

A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Orally-administered Replication-competent Adenovirus Type-4 HIV Vaccine Regimens in Combination With an AIDSVAX? B/E Boost in Healthy, HIV-uninfected Adult Participants

Trial Details:

I Ongoing
PaxVax, NIAID March 01, 2015
Ad4-mgag ,Ad4-EnvC150,AIDSVAX B/E Replicating Ad4 Env C; Replicating Ad4 Gag; Protein Env B,E
Ad4-mgag Viral Vector - Replicating
Ad4-EnvC150 Viral Vector - Replicating
AIDSVAX B/E Protein
USA 60
NCT02771730
https://clinicaltrials.gov/show/NCT02771730